These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 7776969

  • 1. c-fos protooncogene is involved in the mitogenic effect of transforming growth factor-beta in osteoblastic cells.
    Machwate M, Jullienne A, Moukhtar M, Lomri A, Marie PJ.
    Mol Endocrinol; 1995 Feb; 9(2):187-98. PubMed ID: 7776969
    [Abstract] [Full Text] [Related]

  • 2. TGF-beta regulation of nuclear proto-oncogenes and TGF-beta gene expression in normal human osteoblast-like cells.
    Subramaniam M, Oursler MJ, Rasmussen K, Riggs BL, Spelsberg TC.
    J Cell Biochem; 1995 Jan; 57(1):52-61. PubMed ID: 7721958
    [Abstract] [Full Text] [Related]

  • 3. Role of activator protein 1 transcriptional activity in the regulation of gene expression by transforming growth factor beta1 and bone morphogenetic protein 2 in ROS 17/2.8 osteoblast-like cells.
    Palcy S, Bolivar I, Goltzman D.
    J Bone Miner Res; 2000 Dec; 15(12):2352-61. PubMed ID: 11127200
    [Abstract] [Full Text] [Related]

  • 4. Transcriptional activation of c-fos and c-jun protooncogenes by serum growth factors in osteoblast-like MC3T3-E1 cells.
    Okazaki R, Ikeda K, Sakamoto A, Nakano T, Morimoto K, Kikuchi T, Urakawa K, Ogata E, Matsumoto T.
    J Bone Miner Res; 1992 Oct; 7(10):1149-55. PubMed ID: 1456083
    [Abstract] [Full Text] [Related]

  • 5. Transforming growth factor-beta negatively modulates proliferation and c-fos expression of the human endometrial adenocarcinoma cell line HEC-1-A.
    Bergman CA, Talavera F, Christman GM, Baker VV, Roberts JA, Menon KM.
    Gynecol Oncol; 1997 Apr; 65(1):63-8. PubMed ID: 9103392
    [Abstract] [Full Text] [Related]

  • 6. TGF beta alters growth and differentiation related gene expression in proliferating osteoblasts in vitro, preventing development of the mature bone phenotype.
    Breen EC, Ignotz RA, McCabe L, Stein JL, Stein GS, Lian JB.
    J Cell Physiol; 1994 Aug; 160(2):323-35. PubMed ID: 8040190
    [Abstract] [Full Text] [Related]

  • 7. Antisense targeting of c-fos transcripts inhibits serum- and TGF-beta 1-stimulated PAI-1 gene expression and directed motility in renal epithelial cells.
    Kutz SM, Providence KM, Higgins PJ.
    Cell Motil Cytoskeleton; 2001 Mar; 48(3):163-74. PubMed ID: 11223948
    [Abstract] [Full Text] [Related]

  • 8. Transforming growth factor-beta 1 induces growth inhibition of a human medullary thyroid carcinoma cell line despite an increase in steady state c-myc messenger ribonucleic acid levels.
    Khosla S, Oursler MJ, Schroeder MJ, Eberhardt NL.
    Endocrinology; 1994 Nov; 135(5):1887-93. PubMed ID: 7956909
    [Abstract] [Full Text] [Related]

  • 9. Transforming growth factor beta and dexamethasone cooperatively enhance c-jun gene expression and inhibit the growth of human monocytoid leukemia cells.
    Kanatani Y, Kasukabe T, Okabe-Kado J, Hayashi S, Yamamoto-Yamaguchi Y, Motoyoshi K, Nagata N, Honma Y.
    Cell Growth Differ; 1996 Feb; 7(2):187-96. PubMed ID: 8822202
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. TGF-beta induces expression of monocyte chemoattractant JE/monocyte chemoattractant protein 1 via transcriptional factor AP-1 induced by protein kinase in osteoblastic cells.
    Takeshita A, Chen Y, Watanabe A, Kitano S, Hanazawa S.
    J Immunol; 1995 Jul 01; 155(1):419-26. PubMed ID: 7602115
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Regulation of c-fos, c-jun, jun-B, and c-myc messenger ribonucleic acids by gonadotropin and growth factors in cultured pig Leydig cell.
    Hall SH, Berthelon MC, Avallet O, Saez JM.
    Endocrinology; 1991 Sep 01; 129(3):1243-9. PubMed ID: 1651842
    [Abstract] [Full Text] [Related]

  • 16. The cellular protooncogenes c-fos and egr-1 are regulated by prostacyclin in rodent osteoblasts and fibroblasts.
    Glantschnig H, Varga F, Klaushofer K.
    Endocrinology; 1996 Nov 01; 137(11):4536-41. PubMed ID: 8895314
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Fluoride-stimulated [3H]thymidine uptake in a human osteoblastic osteosarcoma cell line is dependent on transforming growth factor beta.
    Reed BY, Zerwekh JE, Antich PP, Pak CY.
    J Bone Miner Res; 1993 Jan 01; 8(1):19-25. PubMed ID: 8427046
    [Abstract] [Full Text] [Related]

  • 19. Serial passage of MC3T3-E1 cells alters osteoblastic function and responsiveness to transforming growth factor-beta1 and bone morphogenetic protein-2.
    Chung CY, Iida-Klein A, Wyatt LE, Rudkin GH, Ishida K, Yamaguchi DT, Miller TA.
    Biochem Biophys Res Commun; 1999 Nov 01; 265(1):246-51. PubMed ID: 10548521
    [Abstract] [Full Text] [Related]

  • 20. Effects of transforming growth factor beta on bone nodule formation and expression of bone morphogenetic protein 2, osteocalcin, osteopontin, alkaline phosphatase, and type I collagen mRNA in long-term cultures of fetal rat calvarial osteoblasts.
    Harris SE, Bonewald LF, Harris MA, Sabatini M, Dallas S, Feng JQ, Ghosh-Choudhury N, Wozney J, Mundy GR.
    J Bone Miner Res; 1994 Jun 01; 9(6):855-63. PubMed ID: 8079661
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.